NCT00468052View on ClinicalTrials.gov

Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

dexmedetomidine

2 micrograms/kilogram as a bolus then 0.7 micrograms/kilogram infusion

DRUG

fentanyl

1 microgram/kilogram as a bolus

Trial Locations (1)

07103

UMDNJ University Hospital, Newark

All Listed Sponsors
lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00468052 - Decrease Emergence Agitation and Provide Pain Relief for Children Undergoing Tonsillectomy & Adenoidectomy | Biotech Hunter | Biotech Hunter